Changeflow GovPing Healthcare & Life Sciences FDA Filing: New Chapter Women's 50+ Multivitamin
Routine Notice Added Final

FDA Filing: New Chapter Women's 50+ Multivitamin

Favicon for www.regulations.gov Regs.gov: Food and Drug Administration
Detected
Email

Summary

The FDA has received a filing from New Chapter regarding their Women's 50+ Multivitamin. This filing pertains to a product supporting immune function, cellular energy, and antioxidants for healthy aging. No specific compliance actions or deadlines are indicated in this notice.

Published by FDA on regulations.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .
View original document View source feed page

What changed

The Food and Drug Administration (FDA) has logged a filing for New Chapter's Women's 50+ Multivitamin. The product is marketed to support immune function, cellular energy, and antioxidants for healthy aging. This appears to be a notification or informational filing rather than a new regulation or enforcement action.

Given the nature of this filing as a notice, there are no immediate compliance actions required for regulated entities. Compliance officers should note this filing as part of the landscape of dietary supplement product notifications. No deadlines or penalties are associated with this specific filing.

Archived snapshot

Mar 18, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Content

There are no documents available to view or download

Attachments 1

New Chapter - Women’s 50+ Multivitamin - Support Immune, cellular energy and antioxidants for healthy aging.

More Information
- Author(s) HFP
Download

Related changes

Favicon for www.fda.gov FDA Warns Mohawksmoke.com for Selling Unauthorized Tobacco Products
Priority review Apr 19, 2026 • FDA Warning Letters • Pharma & Drug Safety
Favicon for changeflow.com The REACH-OUT Trial - Blood Pressure Optimization for Women
Routine Apr 21, 2026 • ClinicalTrials.gov Studies • Healthcare & Life Sciences
Favicon for changeflow.com GLP-2 (Teduglutide) Phase 2 Trial for Environmental Enteric Dysfunction in Undernourished Women, Dhaka
Routine Apr 19, 2026 • ClinicalTrials.gov Studies • Healthcare & Life Sciences

Get daily alerts for Regs.gov: Food and Drug Administration

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

Source

Favicon for www.regulations.gov
Regs.gov: Food and Drug Administration regulations.gov/search?agencyIds=FDA&sortBy=postedDate&sortDirection=desc
Healthcare & Life Sciences

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Press inquiries →

Classification

Agency
FDA
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Drug manufacturers Food manufacturers Healthcare providers
Geographic scope
National (US) National (US)

Taxonomy

Primary area
Healthcare
Operational domain
Compliance
Topics
Dietary Supplements Public Health

Browse Categories

Agriculture & Food Safety 73 Banking & Finance 405 Consumer Protection 89 Courts & Legal 411 Data Privacy & Cybersecurity 89 Defense & National Security 53 Education 55 Energy 100 Environment 151 Gaming 2 Government & Legislation 430 Healthcare 15 Healthcare & Life Sciences 375 Immigration 10 Insurance 75 Labor & Employment 132 Pharma & Drug Safety 21 Professional Licensing 7 Real Estate & Housing 77 Securities & Markets 153 Tax 78 Telecom & Technology 50 Trade & Sanctions 141 Transportation 91

Get alerts for this source

We'll email you when Regs.gov: Food and Drug Administration publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!